Similar Search Results

Mandatory universal drug plan, access to health care and health : evidence from Canada

Wang, Chao; Li, Qing; Sweetman, Arthur; Hurley, Jeremiah E. - In: Journal of health economics 44 (2015), pp. 80-96

Persistent link: https://www.econbiz.de/10011563758

Public drug insurance and children's use of mental health medication : risk-specific responses to lower out-of-pocket treatment costs

Furzer, Jill; Isabelle, Maripier; Miloucheva, Boriana; … - 2021

Persistent link: https://www.econbiz.de/10012624667

The impact of race, income, drug abuse and dependence on health insurance coverage among US adults

Wang, Nianyang; Xie, Xin - In: The European journal of health economics : HEPAC ; … 18 (2017) 5, pp. 537-546

Persistent link: https://www.econbiz.de/10011868688

Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?

Cook, Amanda C.; Sirmans, E. Tice; Wells, Brenda - In: The Geneva papers on risk and insurance - issues and … 49 (2024) 1, pp. 212-226

Persistent link: https://www.econbiz.de/10014446859

The social dilemma of microinsurance : a framed field experiment on free-riding and coordination

Janssens, Wendy; Kramer, Berber - 2012

Persistent link: https://www.econbiz.de/10010190983

Challenges to market-based healthcare for consumers, insurers, and society

Dalton, Tina Marsh - In: Challenges in Classical Liberalism : Debating the …, (pp. 207-225). 2023

Persistent link: https://www.econbiz.de/10014339440

Can health insurance coverage explain the generic competition paradox?

Ferrara, Ida; Kong, Ying - In: Economics letters 101 (2008) 1, pp. 48-52

Persistent link: https://www.econbiz.de/10003787460

Pharmaceutical cost-sharing systems and savings for health care systems from parallel trade

Birg, Laura - 2013

This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems - coinsurance and indemnity insurance - are compared with respect to changes in copayments and public health...

Persistent link: https://www.econbiz.de/10010223102

Estimating the heterogeneous welfare effects of choice architecture : an application to the Medicare prescription drug insurance market

Ketcham, Jonathan D.; Kuminoff, Nicolai V.; Powers, … - 2016

Persistent link: https://www.econbiz.de/10011564385

Nothing for something? : estimating cost and value for beneficiaries from recent medicare spending increases on HMO payments and drug benefits

Pizer, Steven D.; Frakt, Austin B.; Feldman, Roger D. - In: International journal of health care finance and economics 9 (2009) 1, pp. 59-81

Persistent link: https://www.econbiz.de/10003817511

1
2
3
4
5
6
7
8
9
10
Next
Last